The effect of echo contrast agent on Doppler velocity measurements.

The purpose of this investigation was to determine the effect of echo contrast agents on spectral Doppler velocity measurements. SH U 508A was administered by IV injection in 15 patients. The transmitral flow velocity was measured at the E- and A-wave peaks before the start and at the peak of the contrast effect. The Doppler velocity was determined from the Doppler video spectral display and from power spectral analysis of the audio Doppler signal. The Doppler signal intensity was also measured. The Doppler signal intensity increased 17.4 +/- 3.5 dB (p < 0.0001) following echo contrast injection. This was associated with a significant increase in the spectral peak velocity as determined from either the video display or audio analysis. (p < 0.0001). The velocity corresponding to the audio power peak frequency (the modal velocity) did not change significantly (p = NS) and was independent of Doppler signal strength.

Stimulated Acoustic Emission Nonbackscatter Contrast Effect of Microbubbles Seen with Harmonic Power Doppler Imaging.

Transient imaging has been introduced to enhance the signal intensities when using echo contrast agents. However, this phenomenon is not clearly understood. To evaluate the mechanisms of this phenomenon, isolated pig hearts were investigated with different echo imaging techniques in the beating, working heart as well as in an asystolic state without any motion of the heart. The hearts of five German farm pigs (21 +/- 2.5 kg) were surgically explanted and inserted in an artificial circulation providing physiological flow and pressures. Levovist in the dosage of 0.05-0.3 g was injected into the left atrium and contrast effects evaluated in the left ventricular (LV) cavity and in the myocardium with an ultrasound imager (ATL, HDI 3000) equipped with a prototype software for harmonic imaging. Harmonic B-scans and power Doppler registrations were performed with continuous and intermittent recordings (ECG triggered at end-systole) in the beating heart and using an external trigger in the asystolic heart in which perfusion was interrupted for 20 seconds. In the beating pig heart, transient harmonic power Doppler imaging provided intensive opacification of the LV cavity and visible myocardial uptake when ECG triggering was performed. In the asystolic pig heart, with uninterrupted perfusion, both triggered and nontriggered registrations showed contrast signals in the LV cavity and in the myocardium. These findings cannot be explained with the known physics of ultrasound contrast media. Stimulated acoustic emission occurring during disintegration of the microbubbles in the acoustic field would explain this phenomenon, which has not yet been described for Levovist.

Harmonic Power Doppler Contrast Echocardiography: Preliminary Clinical Results.

BACKGROUND: In fundamental and second harmonic echocardiography new contrast media opacify the cavities and reduce the difference in the gray level between the cavity and the myocardium thus obscuring the borders of the myocardium. OBJECTIVES: The aim of the study was to examine the potential usefulness of second harmonic power Doppler imaging (HPD) in providing adequate delineation of the myocardium from the left ventricular (LV) and right ventricular (RV) cavities during intravenous contrast echocardiography. Using HPD, microbubbles in a cavity or a tissue are imaged as colored pixels superimposed on a conventional B-scan image. METHODS: In a pilot study, three healthy volunteers and two patients with ischemic heart disease were investigated using an ATL-HDI 3000 echo system. Four chamber views were obtained using fundamental B-scan, harmonic B-scan two-dimensional echocardiography (H2D) and HPD following intravenous injections of 3 g Levovist(R). RESULTS: Using intermittent scanning/recording, H2D and HPD provided intensive and homogenous contrast effects in the RV and LV cavities. Good delineation of the myocardium was found in all subjects using HPD, whereas in two of three volunteers and in one of two patients ventricular septal and apical endocardial borders were obscured during H2D. No obvious change in myocardial backscatter was visually found with H2D. However, in all three healthy volunteers and in one of two patients, HPD recordings demonstrated patchy and reticular patterns in the myocardium, which were different from the homogenous signals in the LV cavity. These are consistent with imaging of intramyocardial coronary vessels. CONCLUSIONS: HPD with intravenous Levovist is feasible. This technique demonstrated good delineation of ventricular cavities from the myocardium as well as presence of visible contrast in the myocardium. This pilot study justifies further clinical trials to evaluate the clinical benefit of this approach.